Triple negative breast cancer: microRNA expression profile and novel discriminators according to BRCA1 status.

Abstract excerpt

Triple-negative breast cancer (TNBC) represents 15% of breast carcinomas. More than 80% of women with a breast cancer associated with a breast cancer type 1 (BRCA1) mutation develop a TNBC. microRNAs (miRNAs) play critical roles in diverse biological processes and are aberrantly expressed in several human neoplasms including breast cancer, where they function as actors of tumor onset, behavior, and progression....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aged
• Share to Biomarkers, Tumor
• Share to BRCA1 Protein